Marmara University
🇹🇷Turkey
- Country
- 🇹🇷Turkey
- Ownership
- Private
- Established
- 1883-01-16
- Employees
- -
- Market Cap
- -
- Website
- http://www.marmara.edu.tr
Safety and Efficacy of AK0529 in Respiratory Syncytial Virus-Infected Infant Patients
A Phase 2 study evaluates the safety and efficacy of AK0529, an oral RSV fusion protein inhibitor, in infants aged 1-24 months hospitalized with RSV infection. The study found AK0529 to be well tolerated, with a significant reduction in viral load and Wang Respiratory Score at a dosage of 2 mg/kg bid.
© Copyright 2025. All Rights Reserved by MedPath